Regional Analysis
Global Rosacea Treatment Market Regional Insights:
- North America is the leading market for rosacea treatment, accounting for 8% of the global market in 2023. This is attributed to the high prevalence of rosacea in the region, along with the presence of a large number of well-established pharmaceutical companies.
- Europe is another key market for rosacea treatment, accounting for 25.34% of the global market in 2023. The regional is expected to witness significant growth in the coming years, due to the rising awareness about rosacea and the availability of effective treatment options.
- Asia Pacific is the third largest market for rosacea treatment, accounting for 19.34% of the global market in 2023. The regional is expected to witness strong growth in the coming years, due to the increasing prevalence of rosacea and the growing demand for OTC rosacea treatments.
Figure 1. Global Rosacea Treatment Market Share (%), by Region, 2023
![](/images/research-%20methodology/206470global%20rosacea%20treatment%20market-figure-1.png)
Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
|